Time for Testing Incretin Therapies in Early Type 1 Diabetes?-Reference-Cited by-同舟云学术

Time for Testing Incretin Therapies in Early Type 1 Diabetes?

Published:2010-06-01 Issue:6 Volume:95 Page:2607-2609
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Bosi Emanuele¹

Affiliation:

1. Department of Internal Medicine and Diabetes Research Institute, San Raffaele Scientific Institute and Vita Salute San Raffaele University, 20132 Milan, Italy

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/95/6/2607/9066791/jcem2607.pdf

Reference13 articles.

1. Incretin-based therapies for type 2 diabetes mellitus;Lovshin;Nat Rev Endocrinol,2009

2. The biology of incretin hormones;Drucker;Cell Metab,2006

3. Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibodies by enhancing recovery of β-cells;Sherry;Endocrinology,2007

4. Exendin-4 modulates diabetes onset in nonobese diabetic mice;Hadjiyanni;Endocrinology,2008

5. Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation;Kim;Diabetes,2009

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empagliflozin versus Sitagliptin as add-on dual therapy in Egyptian patients with type 2 diabetes inadequately controlled with Metformin: a 12-week randomized, open-label, parallel-group trial;Beni-Suef University Journal of Basic and Applied Sciences;2023-11-08

2. Therapies for Type 1 Diabetes: Is a Cure Possible?;Current Diabetes Reviews;2023-09

3. Role of Glucagon-like peptide-1 “Liraglutide” in Management of Type 1 Diabetes;International Journal Of Pharmaceutical And Phytopharmacological Research;2021

4. Sitagliptin as an Initial Therapy and Differential Regulations of Metabolic Parameters Depending on its Glycemic Response in Subjects with Type 2 Diabetes;Drug Research;2020-11-25

5. Randomized 52-week Phase 2 Trial of Albiglutide Versus Placebo in Adult Patients With Newly Diagnosed Type 1 Diabetes;The Journal of Clinical Endocrinology & Metabolism;2020-03-27